Magenta Therapeutics, Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported net loss was USD 29.17 million compared to USD 22.95 million a year ago. Basic loss per share from continuing operations was USD 0.48 compared to USD 0.39 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.5 USD | +2.43% | -7.53% | +92.07% |
- Stock Market
- Equities
- MGTA Stock
- News Magenta Therapeutics
- Magenta Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023